Low sclerostin levels after long-term remission of acromegaly

PURPOSE: Bone health is compromised in acromegaly resulting in vertebral fractures (VFs), regardless of biochemical remission. Sclerostin is a negative inhibitor of bone formation and is associated with increased fracture risk in the general population. Therefore, we compared sclerostin concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Claessen, Kim M. J. A., Pelsma, Iris C. M., Kroon, Herman M., van Lierop, Antoon H., Pereira, Alberto M., Biermasz, Nienke R., Appelman-Dijkstra, Natasha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763730/
https://www.ncbi.nlm.nih.gov/pubmed/34448099
http://dx.doi.org/10.1007/s12020-021-02850-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763730/
https://www.ncbi.nlm.nih.gov/pubmed/34448099
http://dx.doi.org/10.1007/s12020-021-02850-7

Ejemplares similares